Astec LifeSciences appoints K. Suryanarayan as Chief Financial Officer
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
To enable company to be future-ready by tapping potential in CDMO space
The upcoming portfolio of respiratory products aims to provide effective solutions for a range of respiratory conditions
The company is addressing these observations
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
Eris Lifesciences will be assigned the trademark of these brands by Dr. Reddy's for a consideration of Rs. 275 crore
Time to combine innovation, access and technology to deliver positive patient outcomes
The United States Food and Drug Administration (USFDA) conducted an inspection at Gland Pharma Limited API Facility at JNPC, Visakhapatnam
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
Subscribe To Our Newsletter & Stay Updated